Edition:
United Kingdom

Taisho Pharmaceutical Holdings Co Ltd (4581.T)

4581.T on Tokyo Stock Exchange

7,450JPY
16 Aug 2019
Change (% chg)

¥-10 (-0.13%)
Prev Close
¥7,460
Open
¥7,370
Day's High
¥7,460
Day's Low
¥7,330
Volume
113,100
Avg. Vol
144,817
52-wk High
¥14,130
52-wk Low
¥7,330

Summary

Name Age Since Current Position

Akira Uehara

78 2015 President, Chairman of Subsidiary, Representative Director

Kenichi Fujita

67 2015 President of Subsidiary, Director

Ken Uehara

41 2017 Chairman of Subsidiary, Director

Shigeru Uehara

43 2015 Vice President, President of Subsidiary, Director

Kazuya Kameo

66 2015 Executive Director

Tetsu Watanabe

64 2015 Executive Director

Osamu Kitatani

Executive Officer

Akira Ohira

72 2015 Director

Hiroyuki Uemura

77 2015 Independent Director

Masahiro Mino

2015 Director of Finance

Biographies

Name Description

Akira Uehara

Mr. Akira Uehara has been serving as President and Representative Director in TAISHO PHARMACEUTICAL HOLDINGS CO., LTD., as well as Chairman of the Board of a subsidiary, TAISHO PHARMACEUTICAL CO., LTD., since June 2015. He is also serving as advisor in another subsidiary, Taisho Toyama Pharmaceutical Co., Ltd., where he used to be President and Representative Director.

Kenichi Fujita

Mr. Kenichi Fujita has been serving as Director in TAISHO PHARMACEUTICAL HOLDINGS CO., LTD., as well as President and Representative Director of a subsidiary, Taisho Toyama Pharmaceutical Co., Ltd., since April 2015. He is also serving as Director in another subsidiary, TAISHO PHARMACEUTICAL CO., LTD.

Ken Uehara

Mr. Ken Uehara has been serving as Director in TAISHO PHARMACEUTICAL HOLDINGS CO., LTD., as well as Chairman of the Board of a subsidiary, since June 2017. He is also in charge of Finance & Legal Affairs of the Company. He is also serving as Vice President and Representative Director in a subsidiary, TAISHO PHARMACEUTICAL CO., LTD., as well as Director in another subsidiary, Taisho Toyama Pharmaceutical Co., Ltd. He used to serve as Managing Director of the Company.

Shigeru Uehara

Mr. Shigeru Uehara has been serving as Vice President and Director in TAISHO PHARMACEUTICAL HOLDINGS CO., LTD., as well as President and Representative Director of a subsidiary, TAISHO PHARMACEUTICAL CO., LTD., since June 2015. He used to work for another subsidiary, Taisho Toyama Pharmaceutical Co., Ltd. and another company.

Kazuya Kameo

Mr. Kazuya Kameo has been serving as Executive Director in TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. since June 2015. He is also in charge of QA Supervisor of the Company. He is also serving as Director and Managing Executive Officer in a subsidiary, TAISHO PHARMACEUTICAL CO., LTD. He previously served as Executive Officer in the Company.

Tetsu Watanabe

Mr. Tetsu Watanabe has been serving as Executive Director in TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. since June 2015. He is also in charge of Human Resources & General Affairs & Risk Management Supervisor and Corporate Communication of the Company. He is also serving as Director and Managing Executive Officer in a subsidiary, TAISHO PHARMACEUTICAL CO., LTD. He previously served as Executive Officer in the Company.

Osamu Kitatani

Akira Ohira

Mr. Akira Ohira has been serving as Director in TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. since June 2015. He is also serving as Director in a subsidiary, Taisho Toyama Pharmaceutical Co.,Ltd and working for another subsidiary, TAISHO PHARMACEUTICAL CO., LTD. He used to serve as Vice Chairman of the Board in the Company.

Hiroyuki Uemura

Mr. Hiroyuki Uemura has been serving as Independent Director of TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. since June 2015. He is also serving as Independent Director in HOCHIKI Corporation, as well as working for Mitsui Sumitomo Insurance Company, Limited. He used to work for a subsidiary, TAISHO PHARMACEUTICAL CO., LTD. and another company.

Masahiro Mino